老虎证券

BUZZ-Spruce Biosciences soars after FDA's 'breakthrough therapy' tag for genetic disorder drug

Reuters
2025/10/06
BUZZ-<a href="https://laohu8.com/S/SPRB">Spruce Biosciences</a> soars after FDA's 'breakthrough therapy' tag for genetic disorder drug

** Shares of Spruce Biosciences SPRB.O rise 69% to $14.89 premarket

** Co says U.S. FDA grants "breakthrough therapy" tag for its experimental drug, tralesinidase alfa, to treat Sanfilippo Syndrome Type B

** The condition is a genetic disorder that causes progressive brain damage in children

** The breakthrough therapy tag is meant to speed up development and review of drugs to treat a serious condition or unmet medical need

** Co plans to submit application for U.S. approval in Q1 of 2026

** As of last close, stock down 72% YTD

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10